Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients.
Gounant V, Duruisseaux M, Soussi G, Van Hulst S, Bylicki O, Cadranel J, Wislez M, Trédaniel J, Spano JP, Helissey C, Chouaid C, Molinier O, Dhalluin X, Doucet L, Hureaux J, Cazes A, Zalcman G.
Gounant V, et al. Among authors: soussi g.
Cancers (Basel). 2021 Mar 2;13(5):1040. doi: 10.3390/cancers13051040.
Cancers (Basel). 2021.
PMID: 33801285
Free PMC article.